Filter

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 8 of 8 items for :

  • "SARS-CoV-2" x
  • Refine by access: All content x
Clear All
Neil A Bhowmick Department of Medicine, Cedars-Sinai Cancer, Los Angeles
Department of Research, Greater Los Angeles Veterans Administration, Los Angeles, California, USA

Search for other papers by Neil A Bhowmick in
Google Scholar
PubMed Close
,
Jillian Oft Department of Infectious Diseases, Cedars-Sinai Medical Center, Los Angeles, California

Search for other papers by Jillian Oft in
Google Scholar
PubMed Close
,
Tanya Dorff Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California

Search for other papers by Tanya Dorff in
Google Scholar
PubMed Close
,
Sumanta Pal Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California

Search for other papers by Sumanta Pal in
Google Scholar
PubMed Close
,
Neeraj Agarwal Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah

Search for other papers by Neeraj Agarwal in
Google Scholar
PubMed Close
,
Robert A Figlin Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Robert A Figlin in
Google Scholar
PubMed Close
,
Edwin M Posadas Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Edwin M Posadas in
Google Scholar
PubMed Close
,
Stephen J Freedland Department of Surgery, Cedars-Sinai Cancer, Los Angeles, California

Search for other papers by Stephen J Freedland in
Google Scholar
PubMed Close
, and
Jun Gong Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Jun Gong in
Google Scholar
PubMed Close

Introduction The current pandemic of coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus termed SARS-CoV-2 by the World Health Organization (WHO) and has rapidly spread to at least 114 countries ( Park 2020 ), with

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0165
Volume/Issue:
Volume 27: Issue 9
Free access
Nicola Fazio Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed Close
,
Lorenzo Gervaso Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Molecular Medicine Program, University of Pavia, Pavia, Italy

Search for other papers by Lorenzo Gervaso in
Google Scholar
PubMed Close
,
Thorvardur R Halfdanarson Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed Close
,
Mohamad Sonbol Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA

Search for other papers by Mohamad Sonbol in
Google Scholar
PubMed Close
,
Rachel A Eiring Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Rachel A Eiring in
Google Scholar
PubMed Close
,
Sara Pusceddu Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Sara Pusceddu in
Google Scholar
PubMed Close
,
Natalie Prinzi Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Natalie Prinzi in
Google Scholar
PubMed Close
,
Benedetta Lombardi Stocchetti Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Benedetta Lombardi Stocchetti in
Google Scholar
PubMed Close
,
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close
,
David J Gross Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel

Search for other papers by David J Gross in
Google Scholar
PubMed Close
,
Thomas Walter Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed Close
,
Patrick Robelin Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Patrick Robelin in
Google Scholar
PubMed Close
,
Catherine Lombard-Bohas Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed Close
,
Samuele Frassoni Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy

Search for other papers by Samuele Frassoni in
Google Scholar
PubMed Close
,
Vincenzo Bagnardi Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy

Search for other papers by Vincenzo Bagnardi in
Google Scholar
PubMed Close
,
Lorenzo Antonuzzo Clinical Oncology Unit, Careggi University Hospital, Florence, Italy
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Lorenzo Antonuzzo in
Google Scholar
PubMed Close
,
Clotilde Sparano Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences ’Mario Serio’, University of Florence, Florence, Italy

Search for other papers by Clotilde Sparano in
Google Scholar
PubMed Close
,
Sara Massironi Division of Gastroenterology, and Center for Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, University of Milano-Bicocca School of Medicine, Monza, Italy

Search for other papers by Sara Massironi in
Google Scholar
PubMed Close
,
Fabio Gelsomino Division of Oncology. Department of Hematology and Oncology, University Hospital of Modena, Modena, Italy

Search for other papers by Fabio Gelsomino in
Google Scholar
PubMed Close
,
Alberto Bongiovanni Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy

Search for other papers by Alberto Bongiovanni in
Google Scholar
PubMed Close
,
Nicoletta Ranallo Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy

Search for other papers by Nicoletta Ranallo in
Google Scholar
PubMed Close
,
Salvatore Tafuto Oncologia Sarcomi e Tumori rari, I.R.C.C.S. Ist. Naz. Tumori di Napoli ’G. Pascale’, Napoli, Italy

Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed Close
,
Maura Rossi Oncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Search for other papers by Maura Rossi in
Google Scholar
PubMed Close
,
Mauro Cives Department of Interdisciplinary Medicine, University of Bari ’Aldo Moro’, Bari, Italy

Search for other papers by Mauro Cives in
Google Scholar
PubMed Close
,
Ibrahim Rasul Kakil National Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Search for other papers by Ibrahim Rasul Kakil in
Google Scholar
PubMed Close
,
Hytam Hamid Department of Surgery, Al-Moalem Medical City, Khartoum, Sudan

Search for other papers by Hytam Hamid in
Google Scholar
PubMed Close
,
Alessandra Chirco UO Oncologia Medica ASST Papa Giovanni XXIII, Bergamo, Italy

Search for other papers by Alessandra Chirco in
Google Scholar
PubMed Close
,
Michela Squadroni Oncologia medica, Humanitas Gavazzeni Bergamo, Bergamo, Italy

Search for other papers by Michela Squadroni in
Google Scholar
PubMed Close
,
Anna La Salvia Medical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain

Search for other papers by Anna La Salvia in
Google Scholar
PubMed Close
,
Jorge Hernando Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for other papers by Jorge Hernando in
Google Scholar
PubMed Close
,
Johannes Hofland Department of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands

Search for other papers by Johannes Hofland in
Google Scholar
PubMed Close
,
Anna Koumarianou Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Koumarianou in
Google Scholar
PubMed Close
,
Sabrina Boselli Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Sabrina Boselli in
Google Scholar
PubMed Close
,
Darina Tamayo Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Darina Tamayo in
Google Scholar
PubMed Close
,
Cristina Mazzon Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Cristina Mazzon in
Google Scholar
PubMed Close
,
Manila Rubino Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Manila Rubino in
Google Scholar
PubMed Close
, and
Francesca Spada Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Francesca Spada in
Google Scholar
PubMed Close

Introduction Coronavirus disease (COVID)-19 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that emerged in Wuhan, China, in late 2019 and rapidly spread all over the world causing a

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0395
Volume/Issue:
Volume 30: Issue 6
Restricted access
Jonathan Nyce ACGT Biotechnology, Collegeville, Pennsylvania, USA

Search for other papers by Jonathan Nyce in
Google Scholar
PubMed Close

Introduction COVID-19 is an acute disease that primarily targets the respiratory system, but with increasing evidence of involvement of additional organ systems. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiologic agent

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0439
Volume/Issue:
Volume 28: Issue 2
Free access
Jennifer W Carlisle Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Jennifer W Carlisle in
Google Scholar
PubMed Close
,
Caroline S Jansen Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Caroline S Jansen in
Google Scholar
PubMed Close
,
Mehmet Asim Bilen Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Mehmet Asim Bilen in
Google Scholar
PubMed Close
, and
Haydn Kissick Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Haydn Kissick in
Google Scholar
PubMed Close

balance risks and benefits for each individual and their treatment options ( Lewis 2020 ). Large registries have been established to collect clinical and outcome data on patients with cancer who become infected with the novel SARS-CoV-2 including the

Article Type:
Article Commentary
DOI:
https://doi.org/10.1530/ERC-20-0187
Volume/Issue:
Volume 27: Issue 9
Free access
Nima Sharifi Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA

Search for other papers by Nima Sharifi in
Google Scholar
PubMed Close
and
Charles J Ryan Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA
Masonic Comprehensive Cancer Center, Minneapolis, Minnesota, USA

Search for other papers by Charles J Ryan in
Google Scholar
PubMed Close

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 spurred the coronavirus disease 2019 (COVID-19) pandemic. A notable finding in many affected countries is that men have worse clinical outcomes and

Article Type:
Editorial
DOI:
https://doi.org/10.1530/ERC-20-0133
Volume/Issue:
Volume 27: Issue 6
Free access
Jack Junjie Chan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Jack Junjie Chan in
Google Scholar
PubMed Close
,
Yirong Sim Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Yirong Sim in
Google Scholar
PubMed Close
,
Samuel Guan Wei Ow Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Samuel Guan Wei Ow in
Google Scholar
PubMed Close
,
Joline Si Jing Lim Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Joline Si Jing Lim in
Google Scholar
PubMed Close
,
Grace Kusumawidjaja Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Grace Kusumawidjaja in
Google Scholar
PubMed Close
,
Qingyuan Zhuang Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Qingyuan Zhuang in
Google Scholar
PubMed Close
,
Ru Xin Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Ru Xin Wong in
Google Scholar
PubMed Close
,
Fuh Yong Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Fuh Yong Wong in
Google Scholar
PubMed Close
,
Veronique Kiak Mien Tan Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Veronique Kiak Mien Tan in
Google Scholar
PubMed Close
, and
Tira Jing Ying Tan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Tira Jing Ying Tan in
Google Scholar
PubMed Close

Introduction A novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and spread through human-to-human transmission first emerged in Wuhan, China, in December 2019 ( Zhu et al. 2020 ). Coronavirus

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0157
Volume/Issue:
Volume 27: Issue 9
Free access
Venessa H M Tsang Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia

Search for other papers by Venessa H M Tsang in
Google Scholar
PubMed Close
,
Matti Gild Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia

Search for other papers by Matti Gild in
Google Scholar
PubMed Close
,
Anthony Glover Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Sydney, Australia

Search for other papers by Anthony Glover in
Google Scholar
PubMed Close
,
Roderick Clifton-Bligh Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close
, and
Bruce G Robinson Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia

Search for other papers by Bruce G Robinson in
Google Scholar
PubMed Close

/theory Outcome Thyroid cancer drug interaction Ivermectin Inhibit viral repair Reduced viral cell RNA i n vitro Convalescent plasma IgG or IgM SARS-CoV-2 antibodies as infusion Patients improved and viral load negative N

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0279
Volume/Issue:
Volume 27: Issue 11
Free access
Derek Raghavan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Derek Raghavan in
Google Scholar
PubMed Close
,
Antoinette R Tan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Antoinette R Tan in
Google Scholar
PubMed Close
,
E Shannon Story Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by E Shannon Story in
Google Scholar
PubMed Close
,
Earle F Burgess Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Earle F Burgess in
Google Scholar
PubMed Close
,
Laura Musselwhite Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Laura Musselwhite in
Google Scholar
PubMed Close
,
Edward S Kim Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Edward S Kim in
Google Scholar
PubMed Close
, and
Peter E Clark Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Peter E Clark in
Google Scholar
PubMed Close

surgery, potential added burden on hospital resources, and the risk of exposure to SARS - CoV-2. Genomic evaluation of a HR-positive, HER2-negative invasive breast cancer can be obtained to help guide initial decisions regarding neoadjuvant systemic

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0229
Volume/Issue:
Volume 27: Issue 9
Free access